OA_CVD_19_MARK A_O.png
 
 

OPEN COVID-19 DECLARERS

The COVID-19 pandemic is an unprecedented postwar global crisis. The rapid development, manufacture and provision of therapeutic drugs, vaccines, medical devices, infection control products and the like are central to stopping the spread of COVID-19.

Without seeking compensation, we, declarers commit not to assert certain intellectual property right against any activities whose purpose is stopping the spread of COVID-19, including diagnosis, prevention, containment and treatment.

 

To download executed declaration document, please click the name of declarers.


 

DECLARER WHO SIGNED STANDARD DECLARATION (incl. declarer who expand scope of non-assertion)

Declarers who executed the standard OPEN COVID-19 DECLARATION without any restrictions on the Attachment

 


 

DECLARER WHO MADE LIMITED or EXPANDED DECLARATION


Declarers who executed the OPEN COVID-19 DECLARATION with specific restriction(s) on the Attachment. Implementers who use these declarers’ Intellectual properties must check their declaration documents by clicking the name of declarers.

 
 
 

About Open COVID-19 Declaration

About Open COVID-19 Declaration  The Open COVID-19 Declaration was founded by the Open COVID Founders, IP legal professionals and researchers who address acceleration of the rapid development, manufacture and distribution of therapeutic drugs, vaccines, medical devices, infection control products, software solutions and the like are central to stopping the spread of COVID-19. The Open COVID-19 Declaration calls on intellectual property owners to make their patents, utility models, design patens and copyrights freely available in the fight against the COVID-19 pandemic with respect to the activities whose sole purpose is stopping the spread of COVID-19. Accomplishing this as swiftly as possible calls for a new kind of cooperation between industry, government and academia, that breaks the molds of traditional models. To make or support the Declaration, visit https://www.gckyoto.com/covid19  or contact covid@gckyoto.com.


Founders

Ajinomoto Co., Inc.

Hiroyuki Kojima (Corporate Senior Vice President)

SRL, Inc.

Shunichi Higashi (President and CEO)

NEC Solution Innovators, Ltd.

Hisayoshi Hondou (Executive Vice President)

LSI Medience Corporation

Satoru Kusunoki (Representative Director, Member of the Board, Managing Director)

Canon Inc.

Ken-ichi Nagasawa (Managing Executive Officer)

Hideki Sanatake (Executive Officer)

Kyoto University

Fumihiko Matsuda, Ph.D. (Professor and Director, Center for Genomic Medicine, Graduate School of Medicine)

Konica Minolta, Inc.

Tetsuya Matsueda (Executive Officer, Responsible for Intellectual Property)

Motohiro Makino (General Manager of Corporate Intellectual Property Division)

GenoConcierge Kyoto, Inc.

Hisao Yamasaki (Founder & CEO)

Shimadzu Corporation

Fuminori Inagaki (Managing Executive Officer)

Chanel G.K.

Guillermo Gutierrez (C.E.O.)

Tsubakimoto Chain Co.

Hisao Nishii (Executive Officer, Technology & Research Development Affairs, Senior Maneger, Technology Development Department)

Teijin Limited

Hiroyuki Umetani (Chief officer - Legal, Intellectual Property)

Toyota Motor Corporation

Yosuke Iida (General Manager, Intellectual Property Div.)

Nikon Corporation

Toshikazu Kudo (General Manager of Intellectual Property Division)

Nissan Motor Co., Ltd.

Tomohiro Itou (General Manager, Technology Sales Department)

Tomonori Bekku (General Manager, Intellectual Property Department)

HORIBA, Ltd.

Masaaki MAGARI (Department Manager Intellectual Property Strategy Department, Research & Development Division)

Honda Motor Co., Ltd.

Hirokazu Bessho (Intellectual Property and Standardization Supervisory Unit, Head of Supervisory Unit)

Mitsui Knowledge Industry Co., Ltd.

Masayuki Ooshima (Director)

Yahoo Japan Corporation

Masahito Seno (EVP, President of Legal Management Group)

Hiroshi Takabe (Senior manager Intellectual Property Department, Legal Management Group)

ROHM Co., Ltd.

Takaaki Nagura (General Manager)


 

Steering Committee

 
Kenichi NagasawaManaging Executive Officer, Canon Inc.

Kenichi Nagasawa

Managing Executive Officer, Canon Inc.

Fumihiko Matsuda, Ph.D.Professor and Director, Center for Genomic Medicine, Kyoto University

Fumihiko Matsuda, Ph.D.

Professor and Director, Center for Genomic Medicine, Kyoto University

Hideki SanatakeExecutive Officer, Canon Inc.

Hideki Sanatake

Executive Officer, Canon Inc.

Hisao YamasakiCo-Founder & CEO, GenoConcierge Kyoto, Inc.

Hisao Yamasaki

Co-Founder & CEO, GenoConcierge Kyoto, Inc.